| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE165050
|
||||||||
| GSM5025301 |
S0.1: Sensitive PH039 source tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025302 |
S0.2: Sensitive PH039 source tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025303 |
S2.1: Sensitive PH039 second passage source tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025304 |
S2.3-rep1: Sensitive PH039 second passage source tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025305 |
C1.2: Sensitive PH039 first passage niraparib treated tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025306 |
C2.1: PH039 second passage niraparib treated tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025307 |
C2.2: PH039 second passage niraparib treated tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025308 |
C3.1: Resistant PH039 third passage niraparib treated tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025309 |
148B: Murine sample (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 | |||
| GSM5025310 |
S2.3-rep2: Sensitive PH039 second passage source tumor (array)
|
genomic | 1 |
|
Hu Li | Jun 16, 2021 |
